Neurovascular Devices | Market Insights | Asia Pacific | 2022
Despite the negative, albeit limited, impact of the COVID-19 pandemic in the short term, the Asia Pacific market for neurovascular devices will grow moderately, driven by improving healthcare infrastructure, growing demand, and increasing availability of clinical data supporting the endovascular approach over surgical interventions for treating neurovascular diseases, which will support procedure volume growth in the Asia Pacific region.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for Neurovascular devices in the Asia Pacific region across an 11-year period.